Zeus Bioweb™ is a non-woven composite membrane produced by electrospinning biocompatible PTFE and PU into polymeric nanofibers. Collectively, these nanofibers form a product well-suited for encapsulating implantable stents and scaffolds.
Bioweb™ PTFE/PU composite membranes provide an efficient adhesion platform for stents and scaffolds, enabling low-profile encapsulation over nitinol frames without sutures at a much lower temperature (266 °F / 130 °C) than traditional ePTFE coverings (572 °F / 300 °C). In addition to lower temperature bonding than ePTFE, Bioweb™’s PU layer combined with the PTFE layer provides isotropic mechanical properties, allowing Bioweb™ to encapsulate a wider variety of frames and unique geometries.
As an electrospun product, Bioweb™ possesses excellent isotropic mechanical properties. The electrospinning process produces a composite matrix with microporous qualities similar to that of ePTFE. However, the pores seen in the outer layer of PTFE in Bioweb™ are typically larger (3-5 μm) before sealing, resulting in potentially improved endothelialization when compared to pure ePTFE coverings.
Please contact Zeus today to discover how Bioweb™ stent coverings can help reframe your most challenging implantable applications.
Low-Profile Stent Encapsulation – As a peripheral stent covering, Bioweb™ is well-suited for applications that require the thinnest possible encapsulation.
Implantable Structures in the Body – The microporous surface of Bioweb™ is ideal for covering a variety of other frames and stents, as well as cardio valves and patches, septal occluders, and more.
Biocompatibility – Bioweb™ is made from biocompatible PTFE and PU, is non-toxic, and can safely exist in the body.
EtO Sterilization – Electrospun PTFE and PU in Bioweb™ can be sterilized with EtO.
Low Temperature Encapsulation – Bioweb™ stent encapsulations can be performed at lower temperatures (266 °F / 130 °C) than traditional ePTFE coverings (572 °F / 300 °C), preventing damage to nitinol stent framework.
Non-Reactive – Bioweb™’s minimal chemical reactivity means that this material will not degrade the metal stent (nitinol, cobalt chromium, or stainless steel) framework.
Porous Structure – Bioweb™’s open pore structure makes this material potentially suited for improved tissue in-growth. Additionally, the porous outer layer made from nanofibers creates an increased interface to potentially allow for better endothelialization when compared to conventional, or stretched, ePTFE products. FDA master file available upon request.
Affecting adults and children alike, structural heart disease encompasses non-coronary defects in heart function principally involving the heart’s valves or chambers. Interventional methodologies in this area have grown rapidly in recent years. Improved imaging ...
Peripheral Artery Disease (PAD) refers to diseases of the arteries that supply blood to the limbs and vital organs such as the kidneys and stomach. The most common of these diseases is atherosclerosis, in which plaque accumulates in peripheral arteries, limiting b...
Disruptions in the heart’s electrical system can lead to serious consequences, including death. To treat these conditions, minimally invasive electrophysiology procedures have been developed to restore normal cardiac rhythm. At Zeus, we have been manufacturi...
Coronary artery disease (CAD) is caused by the accumulation of plaque on the inner walls of the arteries that supply blood to the heart. This deadly cardiovascular condition is treated with percutaneous coronary intervention (PCI, commonly known as coronary angiop...